BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 12771537)

  • 1. Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients.
    Shi Y; Yan H; Yuan J; Zhang H; Huang J; Ni Z; Qian J; Fang W
    BMC Nephrol; 2018 May; 19(1):119. PubMed ID: 29792163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and clinical significance of IGF2BP3 in peritoneal dialysate of patients with varying duration of peritoneal dialysis.
    Shao X; Yao L; Fu J; He M; Zhang P
    Clin Transl Sci; 2024 Apr; 17(4):e13774. PubMed ID: 38561910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Peritoneal Equilibration Test in Assessing Folate Transport During Peritoneal Dialysis.
    Lin YL; Lee YC; Lee CC; Wu MH
    J Ren Nutr; 2024 Mar; ():. PubMed ID: 38490516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.
    Redahan L; Davenport A
    J Nephrol; 2016 Jun; 29(3):427-434. PubMed ID: 26616639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of the peritoneal membrane.
    Struijk DG
    NDT Plus; 2008 Oct; 1(Suppl 4):iv29-iv35. PubMed ID: 25983983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysate cancer antigen 125 in long-term peritoneal dialysis patients.
    Ditsawanon P; Supasyndh O; Aramwit P
    Clin Exp Nephrol; 2014 Feb; 18(1):10-5. PubMed ID: 23757048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysate CA125 levels in children on continuous peritoneal dialysis.
    Turhan P; Sever L; Caliskan S; Kasapcopur O; Sever A; Hacibekiroglu M; Arisoy N
    Pediatr Nephrol; 2005 Nov; 20(11):1615-21. PubMed ID: 16133054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.
    Krediet RT
    Perit Dial Int; 2001; 21(6):560-7. PubMed ID: 11783764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?
    Cheema H; Bargman JM
    Perit Dial Int; 2013; 33(4):349-52. PubMed ID: 23843586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effluent CA 125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen.
    Fusshöller A; Grabensee B; Plum J
    Kidney Blood Press Res; 2003; 26(2):118-22. PubMed ID: 12771537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
    van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT
    Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence.
    Fußhöller A; Zur Nieden S; Grabensee B; Plum J
    J Am Soc Nephrol; 2002 Apr; 13(4):1055-1060. PubMed ID: 11912266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
    Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.